LFCR SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES LIFECORE BIOMEDICAL, INC.

LFCR SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES LIFECORE BIOMEDICAL, INC.

Lifecore shareholders will receive just $6.28 per share in a transaction valued at up to $663.7 million; Ademi LLP is investigating the deal price, benefits to company insiders, and restrictions on competing offers

CLICK HERE TO JOIN

MILWAUKEE, Sept. 28, 2026 /PRNewswire/ -- Ademi LLP is investigating whether the proposed acquisition of Lifecore (Nasdaq: LFCR) by Webster Equity Partners, provides fair value to Lifecore's public shareholders and whether Lifecore's Board adequately protected shareholder interests in negotiating and approving the transaction.

Are You a Lifecore Shareholder?
If you own Lifecore shares, Ademi LLP would like to hear from you about the proposed acquisition and your rights as a shareholder.

You may also contact Guri Ademi at gademi@ademilaw.com or toll-free at 866-264-3995.
There is no cost or obligation to you.

What Is Ademi LLP Investigating?
The exchange ratio and whether it adequately reflects Lifecore's value and future prospects;

Substantial change-of-control benefits available to Lifecore insiders in connection with the transaction;

Restrictions on competing transactions, including a significant termination penalty that may discourage another potential buyer from making a superior proposal; and

The conduct of Lifecore's Board of Directors in negotiating and approving the transaction and whether the Board fulfilled its duties to public shareholders.

What Should Lifecore Shareholders Do?
Contact Ademi LLP to discuss your rights and our investigation. There is no cost or obligation to you.

Guri AdemiAdemi LLP
Toll Free: (866) 264-3995
Email: gademi@ademilaw.com

About Ademi LLP
Ademi LLP represents investors in shareholder litigation involving mergers, acquisitions, buyouts, and individual shareholder rights.

Attorney advertising. Prior results do not guarantee similar outcomes.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lfcr-shareholder-alert-ademi-llp-investigates-whether-buyout-fairly-values-lifecore-biomedical-inc-302891600.html

SOURCE Ademi LLP